Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))

Beste Mutlu; Kfir Sharabi; Jee Hyung Sohn; Bo Yuan; Pedro Latorre-Muro; Xin Qin; Jin Seon Yook; Hua Lin; Deyang Yu; João Paulo G. Camporez; Shingo Kajimura; Gerald I. Shulman; Sheng Hui; Theodore M. Kamenecka; Patrick R. Griffin; Pere Puigserver

doi:10.1016/j.chembiol.2025.01.005

Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))

Beste Mutlu, Kfir Sharabi, Jee Hyung Sohn, Bo Yuan, Pedro Latorre-Muro, Xin Qin, Jin Seon Yook, Hua Lin, Deyang Yu, João Paulo G. Camporez, Shingo Kajimura, Gerald I. Shulman, Sheng Hui, Theodore M. Kamenecka, Patrick R. Griffin, Pere Puigserver

Institute of Biochemistry, Food Science and Nutrition

The Hebrew University of Jerusalem

Research output: Contribution to journal › Comment/debate

Abstract

(Cell Chemical Biology 31, 1772–1786.e1–e5; October 17, 2024) Author B.M. is an employee of Elsevier, the publisher of Cell Chemical Biology, in the role of scientific editor for Developmental Cell. This article was written before the author was employed by Elsevier, and the author had no role in the editorial evaluation, peer-review process, or decision to accept the article. The article has been updated online to disclose this information.

Original language	English
Pages (from-to)	379
Number of pages	1
Journal	Cell Chemical Biology
Volume	32
Issue number	2
DOIs	https://doi.org/10.1016/j.chembiol.2025.01.005
State	Published - 20 Feb 2025

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmacology
Drug Discovery
Clinical Biochemistry

Access to Document

10.1016/j.chembiol.2025.01.005

Cite this

Mutlu, B., Sharabi, K., Sohn, J. H., Yuan, B., Latorre-Muro, P., Qin, X., Yook, J. S., Lin, H., Yu, D., Camporez, J. P. G., Kajimura, S., Shulman, G. I., Hui, S., Kamenecka, T. M., Griffin, P. R., & Puigserver, P. (2025). Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001)). Cell Chemical Biology, 32(2), 379. https://doi.org/10.1016/j.chembiol.2025.01.005

Mutlu, Beste ; Sharabi, Kfir ; Sohn, Jee Hyung et al. / Erratum : Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001)). In: Cell Chemical Biology. 2025 ; Vol. 32, No. 2. pp. 379.

@article{6991cc2d68b04616bbc59507901e9b6b,

title = "Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))",

abstract = "(Cell Chemical Biology 31, 1772–1786.e1–e5; October 17, 2024) Author B.M. is an employee of Elsevier, the publisher of Cell Chemical Biology, in the role of scientific editor for Developmental Cell. This article was written before the author was employed by Elsevier, and the author had no role in the editorial evaluation, peer-review process, or decision to accept the article. The article has been updated online to disclose this information.",

author = "Beste Mutlu and Kfir Sharabi and Sohn, {Jee Hyung} and Bo Yuan and Pedro Latorre-Muro and Xin Qin and Yook, {Jin Seon} and Hua Lin and Deyang Yu and Camporez, {Jo{\~a}o Paulo G.} and Shingo Kajimura and Shulman, {Gerald I.} and Sheng Hui and Kamenecka, {Theodore M.} and Griffin, {Patrick R.} and Pere Puigserver",

note = "Publisher Copyright: {\textcopyright} 2025 Elsevier Ltd",

year = "2025",

month = feb,

day = "20",

doi = "10.1016/j.chembiol.2025.01.005",

language = "الإنجليزيّة",

volume = "32",

pages = "379",

number = "2",

}

Mutlu, B, Sharabi, K, Sohn, JH, Yuan, B, Latorre-Muro, P, Qin, X, Yook, JS, Lin, H, Yu, D, Camporez, JPG, Kajimura, S, Shulman, GI, Hui, S, Kamenecka, TM, Griffin, PR & Puigserver, P 2025, 'Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))', Cell Chemical Biology, vol. 32, no. 2, pp. 379. https://doi.org/10.1016/j.chembiol.2025.01.005

Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001)). / Mutlu, Beste; Sharabi, Kfir; Sohn, Jee Hyung et al.
In: Cell Chemical Biology, Vol. 32, No. 2, 20.02.2025, p. 379.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))

AU - Mutlu, Beste

AU - Sharabi, Kfir

AU - Sohn, Jee Hyung

AU - Yuan, Bo

AU - Latorre-Muro, Pedro

AU - Qin, Xin

AU - Yook, Jin Seon

AU - Lin, Hua

AU - Yu, Deyang

AU - Camporez, João Paulo G.

AU - Kajimura, Shingo

AU - Shulman, Gerald I.

AU - Hui, Sheng

AU - Kamenecka, Theodore M.

AU - Griffin, Patrick R.

AU - Puigserver, Pere

PY - 2025/2/20

Y1 - 2025/2/20

N2 - (Cell Chemical Biology 31, 1772–1786.e1–e5; October 17, 2024) Author B.M. is an employee of Elsevier, the publisher of Cell Chemical Biology, in the role of scientific editor for Developmental Cell. This article was written before the author was employed by Elsevier, and the author had no role in the editorial evaluation, peer-review process, or decision to accept the article. The article has been updated online to disclose this information.

AB - (Cell Chemical Biology 31, 1772–1786.e1–e5; October 17, 2024) Author B.M. is an employee of Elsevier, the publisher of Cell Chemical Biology, in the role of scientific editor for Developmental Cell. This article was written before the author was employed by Elsevier, and the author had no role in the editorial evaluation, peer-review process, or decision to accept the article. The article has been updated online to disclose this information.

UR - http://www.scopus.com/inward/record.url?scp=85215232278&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2025.01.005

DO - 10.1016/j.chembiol.2025.01.005

M3 - تعليقَ / نقاش

C2 - 39814023

SN - 2451-9456

VL - 32

SP - 379

JO - Cell Chemical Biology

JF - Cell Chemical Biology

IS - 2

ER -

Mutlu B, Sharabi K, Sohn JH, Yuan B, Latorre-Muro P, Qin X et al. Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001)). Cell Chemical Biology. 2025 Feb 20;32(2):379. doi: 10.1016/j.chembiol.2025.01.005

Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this